Immunization with a novel dc-targeting lentiviral vector induces polyfunctional cd8 t cell responses and therapeutic anti-tumor immunity

被引：0
作者：
Robbins, S. H. [1 ,2 ]
Clarke, B. Kelley [1 ]
Odegard, J. M. [1 ]
Tareen, S. U. [1 ]
Van Hoeven, N. [1 ]
Campbell, D. J. [1 ]
Nicholai, C. J. [1 ]
Slough, M. M. [1 ]
Vin, C. [1 ]
Baltimore, D. [2 ]
Reed, S. G. [1 ]
Dubensky, T. W., Jr. [1 ]
机构：
[1] Immune Design Corp, Seattle, WA USA
[2] CALTECH, Pasadena, CA 91125 USA
来源：
CYTOKINE | 2011年 / 56卷 / 01期
关键词：
D O I：
10.1016/j.cyto.2011.07.246
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] A strategy for uncovering germline variants altering anti-tumor CD8 T cell response
    Ulaganathan, Vijay Kumar
    Vasileva, Martina H.
    [J]. JOURNAL OF GENETICS AND GENOMICS, 2023, 50 (05) : 353 - 361
  • [42] A strategy for uncovering germline variants altering anti-tumor CD8 T cell response
    Vijay Kumar Ulaganathan
    Martina H.Vasileva
    [J]. Journal of Genetics and Genomics, 2023, 50 (05) : 353 - 361
  • [43] Therapeutic vaccination enhances 4-1BB-mediated anti-tumor CD8 T cell immunity against poorly immunogenic haematological cancers
    Doff, B.
    Soon, M.
    Kobayashi, T.
    McKee, S.
    Mattarollo, S.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 810 - 810
  • [44] TARGETING WILDTYPE IL-2 TO CD8 T CELLS INDUCES POTENT ANTI-TUMOR IMMUNE RESPONSES AND DECREASES IL-2 MEDIATED TOXICITY
    Ramasamy, Selvi
    Nardozzi, Joanathan
    Boi, Shannon
    Swain, Joanna
    Coyle, Anthony
    Gulla, Stefano
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1141 - A1141
  • [45] Riplet regulates effector function of CD8 T cells and suppresses T cell-mediated anti-tumor immune responses
    Iwamoto, Asuka
    Tsukamoto, Hirotake
    Nakayama, Hideki
    Oshiumi, Hiroyuki
    [J]. CANCER SCIENCE, 2022, 113
  • [46] IRF4 overexpression in therapeutic anti-tumor Cd8 T cells inhibits tumor growth by driving functional state transition of therapeutic and endogenous CD8 T cells in tumors
    Yan, hui
    Zhang, Hedong
    Zou, Dawei
    Fu, Jinfei
    Zhang, Xiaolong
    Xiao, Xiang
    Guo, Yang
    Wang, Guohua
    Yu, Anze
    Li, Xian C.
    Chen, Wenhao
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01)
  • [47] Immo-bile-izing CD8+T cell anti-tumor immunity
    Read, Scott A.
    Ahlenstiel, Golo
    [J]. IMMUNITY, 2025, 58 (03) : 532 - 534
  • [48] Autophagy Regulation of Metabolism Is Required for CD8+ T Cell Anti-tumor Immunity
    DeVorkin, Lindsay
    Pavey, Nils
    Carleton, Gillian
    Comber, Alexandra
    Ho, Cally
    Lim, Junghyun
    McNamara, Erin
    Huang, Haochu
    Kim, Paul
    Zacharias, Lauren G.
    Mizushima, Noboru
    Saitoh, Tatsuya
    Akira, Shizuo
    Beckham, Wayne
    Lorzadeh, Alireza
    Moksa, Michelle
    Cao, Qi
    Murthy, Aditya
    Hirst, Martin
    DeBerardinis, Ralph J.
    Lum, Julian J.
    [J]. CELL REPORTS, 2019, 27 (02): : 502 - +
  • [49] DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses
    Lee, Jino
    Kim, Jihye
    Lee, Jeewon
    Shin, Sung Jae
    Shin, Eui-Cheol
    [J]. CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2014, 3 (02) : 235 - 243
  • [50] OX40 signals are crucial for CD8 T cell survival in both primary and secondary anti-tumor responses
    Song, AH
    Tang, XH
    Harms, KM
    Croft, M
    [J]. FASEB JOURNAL, 2005, 19 (04) : A907 - A907
12345